Status:
COMPLETED
Role of PET/MRI in Head and Neck Cancer
Lead Sponsor:
University of Pecs
Conditions:
Head and Neck Cancer
Benign Neoplasm
Eligibility:
All Genders
41-88 years
Brief Summary
Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.
Detailed Description
This study was assessed the role of Diffusion weighted imaging (DWI) in discriminating between benign and malignant lesions in Head and neck cancer as well as studying the relationship between glucose...
Eligibility Criteria
Inclusion
- Proved Head and neck cancer
- Underwent PET/CT and PET/MRI
- Lymph nodes due to primary Head and neck cancer.
- For healthy subject:
- No previous history of malignancy.
- no inflammation or infection in the neck region.
- lymph node size \<10mm.
Exclusion
- patients treated before by radiotherapy / chemoradiotherapy
- patients underwent surgery
- artifacts
Key Trial Info
Start Date :
April 12 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 22 2020
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04360993
Start Date
April 12 2016
End Date
January 22 2020
Last Update
December 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.